大屠杀是人类历史上最痛苦的灾难之一。今天寻求心理治疗帮助的幸存者,现在七十多岁了,经常表现出创伤后应激障碍(PTSD)的症状,抑郁症,或长期的悲伤障碍。已建立的创伤后应激障碍心理治疗(如认知行为治疗,心理动力疗法)已主要针对年轻人和中年人进行了测试和评估;只有很少的研究在老年时对它们进行了检查。我们没有针对大屠杀幸存者的任何治疗模式的治疗结果研究。此外,需要针对特定年龄组的PTSD和其他压力相关精神障碍的治疗。包括生活回顾和叙事曝光在内的叙事方法似乎很好地满足了老年人回顾生活的自然需求,并且非常有效。然而,大多数关于生活回顾疗法(LRT)疗效的研究集中在晚年抑郁症.缺乏疗效研究评估LRT对经历过创伤事件的老年人PTSD症状的影响。
这项研究的主要目标是评估LRT对大屠杀幸存者(LRT-HS)对PTSD症状和相关心理健康问题(抑郁症,焦虑,长时间的悲伤),与支持性对照组相比。次要目标是确定似乎特别受益于治疗的参与者的特征。拟议的研究是一项随机的,包括患有一种或多种创伤相关疾病的大屠杀幸存者在内的对照随访试验。LRT治疗包括20-25个疗程。在治疗阶段之前和之后,参与者在这两个条件将被评估。随访将在治疗后6个月进行。需要80的样本量(包括脱落率)。
老年人创伤相关疾病的有效治疗非常重要,也因为创伤和损失的可能性随着年龄的增长而增加。因为这项研究是针对这个特殊的受累人群进行的,我们相信,结果可以很容易地转移到其他样品。
ISRCTN,ISRCTN12823306。2018年3月31日注册-回顾性注册(2017年12月22日首次参与者)。
The Holocaust was one of the most traumatic catastrophes in recorded human history. Survivors seeking psychotherapeutic help today, now in their seventies and older, often show symptoms of a posttraumatic stress disorder (PTSD), depression, or prolonged grief disorder. Established psychological treatments for PTSD (e.g. cognitive behaviour therapy, psychodynamic therapies) have been tested and assessed mainly with young and middle-aged adults; only very few studies examined them in old age. There is no therapy outcome study known to us for any treatment mode for Holocaust survivors. Moreover, there is a need for an age group-specific treatment of PTSD and other stress-related mental disorders. A narrative approach including life-
review and narrative exposure seems to meet very well the natural need of older people to
review their lives and is highly effective. However, most studies on the efficacy of life
review therapy (LRT) focus on late-life depression. There is a lack of efficacy studies evaluating the effect of LRT on PTSD symptoms in older individuals that have experienced traumatic events.
The main goal of this study is to evaluate the effect of LRT for Holocaust survivors (LRT-HS) on symptoms of PTSD and related mental health problems (depression, anxiety, prolonged grief), compared to a supportive control group. A secondary goal is to identify the characteristics of participants that seem to especially benefit from the treatment. The proposed study is a randomised, controlled follow-up trial including Holocaust survivors with one or more trauma-related disorders. The LRT treatment consists of 20-25 sessions. Before and after the treatment phase, participants in both conditions will be assessed. Follow-up will take place 6 months after the treatment. A sample size of 80 is required (drop-out rate included).
Efficacious treatments for trauma-related disorders in older people are of high importance, also because the probability of traumatisation and loss increases with age. Because this study is conducted with this specific group of multiply traumatised people, we are convinced that the results can easily transfer to other samples.
ISRCTN, ISRCTN12823306. Registered 31 March 2018 - Retrospectively registered (first participant 22 December 2017).